Cannabis Inhaler Could Spread Use of Medical Marijuana 
|
By HospiMedica International staff writers Posted on 25 May 2015 |
|
Image: The Syqe Exo Inhaler device (Photo courtesy of Syqe Medical).
An innovative portable thermal-metered-dose inhaler (tMDI) for Cannabis provides doctors with the ability to supervise the medical marijuana process.
The Syqe Inhaler is a pocket-sized device that utilizes selective dosing, real-time thermal and flow controllers, lung interfacing, and wireless connectivity to deliver a metered dose of tetrahydrocannabinol (THC), allowing patients to reach an optimum balance between symptom relief and psychoactivity. The platform is further comprised of proprietary raw Cannabis structural-modification methods, uniquely identified preloaded cartridges, and a linked clinical database that serves physicians, researchers, and healthcare entities.
Also available is the Syqe Inhaler Exo, which delivers a fixed 100 microgram dose of Cannabis for professional healthcare use. The Exo features a caregiver interface for nurses and other certified caregivers in hospital pain clinics, cancer centers, intensive care units (ICUs), and other medical institutions. Both inhalers differ from traditional vaporizers by using granules that contain standardized portions of whole Cannabis, in sizes as small as 1 mg. Device connectivity further helps monitor use and determine best dosages for different conditions.
Uniquely, 75% of the parts of the Syqe Inhaler prototype devices were printed on Stratasys (Rehovot, Israel) three dimensional (3D) printers, a convenience that sped up the manufacturing process. The Syqe Inhaler and the Syqe Inhaler Exo are products of Syqe Medical (Tel Aviv, Israel) and have been authorized for use in Israel since October 2014.
“Different materials were selected for the four main components of the device - the shell, chassis, airway, and thermal housing, which allowed them to have rigidity, clarity, biocompatibility, and heat resistance for the inhaler,” said Perry Davidson, CEO of Syqe Medical. “Since metered dose inhalation of raw botanicals is a highly unconventional undertaking, we had to develop the tooling and machines for many of our processes. More than half of our production equipment, jigs, and analytical tools were printed in house.”
Related Links:
Syqe Medical
The Syqe Inhaler is a pocket-sized device that utilizes selective dosing, real-time thermal and flow controllers, lung interfacing, and wireless connectivity to deliver a metered dose of tetrahydrocannabinol (THC), allowing patients to reach an optimum balance between symptom relief and psychoactivity. The platform is further comprised of proprietary raw Cannabis structural-modification methods, uniquely identified preloaded cartridges, and a linked clinical database that serves physicians, researchers, and healthcare entities.
Also available is the Syqe Inhaler Exo, which delivers a fixed 100 microgram dose of Cannabis for professional healthcare use. The Exo features a caregiver interface for nurses and other certified caregivers in hospital pain clinics, cancer centers, intensive care units (ICUs), and other medical institutions. Both inhalers differ from traditional vaporizers by using granules that contain standardized portions of whole Cannabis, in sizes as small as 1 mg. Device connectivity further helps monitor use and determine best dosages for different conditions.
Uniquely, 75% of the parts of the Syqe Inhaler prototype devices were printed on Stratasys (Rehovot, Israel) three dimensional (3D) printers, a convenience that sped up the manufacturing process. The Syqe Inhaler and the Syqe Inhaler Exo are products of Syqe Medical (Tel Aviv, Israel) and have been authorized for use in Israel since October 2014.
“Different materials were selected for the four main components of the device - the shell, chassis, airway, and thermal housing, which allowed them to have rigidity, clarity, biocompatibility, and heat resistance for the inhaler,” said Perry Davidson, CEO of Syqe Medical. “Since metered dose inhalation of raw botanicals is a highly unconventional undertaking, we had to develop the tooling and machines for many of our processes. More than half of our production equipment, jigs, and analytical tools were printed in house.”
Related Links:
Syqe Medical
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Tourniquet System
heidi– mein Tourniquet
New
Resorbable Bovine Collagen Membrane
GenDerm
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
